A 38-year-old female had felt exertional dyspnea for six months. Physical examination and laboratory data, including angiotensin-converting enzyme, failed to diagnose sarcoidosis. Her chest X-ray showed cardiomegaly but no hilar lymph node enlargement. Holter ECGshowed nonsustained and sustained ventricular tachycardias, monomorphicor polymorphic tachycardia.
Introduction
Cardiac sarcoidosis was first described by Bernstein in 1929 (1). It constituted 20% of sarcoid patients (2). Electrocardiographic findings in cardiac sarcoidosis included ventricular premature beats, ventricular tachycardia and fibrillation, AV block, conduction defects and ST-T changes (3-5). However, in previous reports we could not find polymorphic ventricular tachycardias in cardiac sarcoidosis. Wetreated a patient with cardiac sarcoidosis who had frequent ventricular tachyarrhythmias of monomorphic or polymorphic form, where combination therapy of low-dose metoprolol, cibenzoline and corticosteroids was effective for the treatment of tachyarrhythmias.
Case Report
A 38-year-old female had complained of palpitation and exertional dyspnea for about six months. Physical examination revealed an irregular radial pulse of about 70/min. Her blood pressure as measured by a sphygmomanometer was 102/60 mmHgin the right brachial artery. Uveitis was not found by an ophthalmologist. Skin rash was not observed. Thejugular veins were slightly engorged, but enlarged lymph nodes were not palpable anywhere. Cardiac dullness was extended and third heart sound was audible. No peripheral edema was evident.
Hepatomegalyand splenomegaly were not found. Electrocardiography showed premature ventricular beats, left atrial overloading, Q wave in leads I and aVL, and negative T in leads I, II, III, aVL, AVF and V4_5. PQ interval was 0.20 seconds, QRS 0.10 seconds and QTC 0.44 seconds (Fig. 1) . Chest X-ray showed cardiomegaly and slight pulmonary venous congestion but there was no hilar lymph node enlargement. Cardiothoracic ratio was 60%. In Holter ECG, 6,462 premature ventricular beats, 1,154 couplets of premature ventricular beats and 678 nonsustained ventricular tachycardias a day were observed (Table 1) . Someventricular tachycardias were polymorphic (Fig. 2) . Echocardiography demonstrated a dilated and generally hypo-or akinetic left ventricle. The left ventricular diastolic dimension was 67 mmwith an interventricular septal thickness of 4.3 mmand posterior wall thickness of 6.9 mm.Ejection fraction was 19%. 201Tl scintigraphy showed multiple defects of uptake. Coronary angiography revealed no stenosis of the coronary arteries and left ventriculography showed generalized hypo-and akinesis of the left ventricle. Endomyocardial biopsy specimen from the right ventricle disclosed the existence of myocardial involvement of sarcoidosis (Fig. 3) . Scalen node biopsy specimen also indicated the infiltration of sarcoidosis. In laboratory examination findings, CRP and erythrocyte sedimentation rate were normal. Serum sodium was 140 mEq/ 1, serum potassium 3.7 mEq/1, serum calcium 4.7 mEq/1, serum chloride 105 mEq/1, serum urea nitrogen ll.3 mg/dl and creatinine 0.7 mg/dl. CPK was 26 (24-195) |ll/1 and LDH 272 mU/ml. Myosin light chain was 1.0 (<2.5) ng/ml. IgG was 1,527 mg/dl, IgA 194 mg/dl and IgM 213 mg/dl. Angiotensinconverting enzyme was 15.6 (<20) U/ml and OKT4/OKT8 ratio was 1.72 (1. 18-2.00). The above laboratory data were all normal. Tuberculin skin test was 7x8 mm.
Clinical course
The patient was admitted on February 9, 1 992 with sustained monomorphic ventricular tachycardia. DC shock of 300 joules was performed. After recovery to sinus rhythm, premature ventricular beats were frequently observed and lidocaine was administered intravenously. However, as this treatment was ineffective for ventricular arrhythmias, cibenzoline of 200 mg/ day was administered in addition to diuretics and nitrates. In Holter ECGrecorded on March 18, 3,516 ventricular premature beats, 53 couplets and two triplets were observed. Thus, cibenzoline was partially effective and the dose was increased to 300 mg/day. Moreover, 5 mg metoprolol was added and was increased gradually to 20 mg/day. A diagnosis of cardiac sarcoidosis was madeand 40 mgprednisolone was started from April 7. After the combination therapy, Holter ECGon April 23 showed 1 ,7 16 premature ventricular beats and 3 1 couplets; that on August 28 showed only 163 premature ventricular beats a day. However, the cardiothoracic ratio in the chest X-ray and left ventricular dimension and ejection fraction determined by echocardiography remained unchanged, while angiotensinconverting enzyme decreased to within normal range (to 6 U/ ml). Up to April 1993, the dose ofcorticosteroids is 10 mg/day, and 300 mg cibenzoline and 20 mg metoprolol has been continuously administered. This patient is still alive 21 months after starting combination therapy and being treated in the outpatient clinic , although she still feels slight exertional dyspnea.
Discussion
The major cause of death of sarcoidosis is cardiac involvement. Some ECGabnormalities are found in 22-51% of patients with sarcoidosis (3). Various arrhythmias are observed in patients with cardiac sarcoidosis and the most common cause of death has been heart block (4). However, Sekiguchi et al reported that pacemaker implantation reduces the death rate from heart block in cardiac sarcoidosis in Japan, and that heart failure and ventricular arrhythmias are increasing by the causes of death (6) . The ventricular arrhythmias are sometimes difficult to control in cardiac sarcoidosis. Large doses ofprocainamide or diphenylhydantoin have been used (4). In the present patient, the ventricular tachyarrhythmias were sometimes polymorphic. The mechanism of ventricular tachycardias in the present patient was unknown; there was no mineral imbalance and no drug intake, but the QTinterval was slightly long. The slightly long QT interval may be caused by diffuse myocardial involvement and the multiple myocardial lesion maycause polymorphic ventricular tachycardias. Since lidocaine (class Ib) infusion was ineffective for the treatment ofventricular arrhythmias in the present patient, cibenzoline was chosen as the drug of class la according to Vaughan-Williams ' classification (7). The ventricular arrhythmia in the present patient was reduced after administration of cibenzoline and furthermore decreased after combination therapy with low-dose metoprolol and corticosteroids. In some patients with cardiac sarcoidosis, remission of the cardiac lesion and improvement of wall motion abnormalities have been observed after corticosteroid therapy (8) . These patients usually have an active myocardial sarcoid lesion and the serum angiotensin-converting enzyme level is high.
However, in the present patient, CRP and the erythrocyte sedimentation rate were normal, and serum-angiotensin converting enzyme was in the upper limit, although serum angiotensin-converting enzymedecreased to within normal range after start of corticosteroid therapy. Therefore, the suppression of ventricular arrhythmia may be mainly due to cibenzoline and/or low-dose beta blocker, while corticosteroids may partially contribute to the beneficial effect. It has been reported that in patients of polymorphic ventricular tachycardias with myocardial ischemia, class la drugs are often effective (9) . Similarly, a class la drug, cibenzoline in the present case, was effective for the treatment of polymorphic ventricular tachycardia.
On the other hand, recently, low-dose beta blockers have been used for the treatment of heart failure; they are not only effective for symptomrelief but also for improvementof the prognosis. The efficacy maydepend on the upregulation of beta receptors and the cardiac protective action of beta blockers. These beneficial effects of beta blockers for the failed heart and combination therapy of low-dose betablockers with cibenzoline and corticosteroids may contribute in the long term to a good prognosis for patients with severe myocardial involvement of sarcoidosis.
